Skip to main content
OpenTrials
Completed

NCT Number: NCT05795985

Role of Faecal Calprotectin in Patients With Abdominal Pain

The evaluation of patients with abdominal pain is a challenge for the emergency physician and the selection of patients for second-level radiological examinations or endoscopic procedures is not always easy to perform. Faecal calprotectin could be a useful diagnostic marker to distinguish between "organic" or "functional" form and its determination could be helpful to select patients for further examinations, in the context of emergency setting.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Inflammation Pathologic Processes Pathological Conditions, Signs and Symptoms

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

Fondazione Policlinico Universitario A. Gemelli IRCCS

Roma, 00168, Italy

Who can participate

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • patients with abdominal pain and/or diarrhea and/or rectal bleeding

Exclusion criteria

  • patients with age < 18 years
  • pregnant women;
  • patients with oncological, cardiological, nephrological terminal diseases;
  • patients on antibiotic therapy or who have taken it during the last month;
  • patients with a history of colic resection or gastrointestinal surgery;
  • patients with a previous diagnosis of inflammatory bowel disease (Crohn's disease, ulcerative colitis)

Treatment and study plan

calprotectin levels

Diagnostic Test

dosage of calprotectin levels in patients with abdominal pain

Primary outcomes

  1. inflammation

    Time frame: 3 days

    assess the degree of intestinal inflammation by fecal calprotectin assay in patients with abdominal pain

Sponsors and collaborators

Lead sponsor

Fondazione Policlinico Universitario Agostino Gemelli IRCCS

Other

Registry information

Official study title

Role of Faecal Calprotectin in Patients Presenting to the Emergency Department With Abdominal Pain

Important dates

Study start
2021
Primary completion
2022
Study completion
2023
First posted
Apr 3, 2023
Registry last updated
Apr 4, 2023

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.